Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Morgan Stanley $5.5 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
Province of British Columbia $3.5 billion global bond offering
The investment-grade bonds are due 2028
Kantar $1.8 billion refinancing
The transaction comprised a high-yield notes offering and borrowing under an incremental term loan as part of a refinancing
SailPoint $1.4 billion IPO
The shares are listed on the Nasdaq Global Select Market
Hamilton Lane $252 million follow-on offering
The shares are listed on Nasdaq
Eli Lilly $6.5 billion notes offering
The investment-grade notes are due 2028, 2030, 2032, 2035, 2055 and 2065
Sun Country Airlines Holdings $100 million secondary offering
The shares are listed on the Nasdaq Global Select Market
IBM $4.75 billion and €3.5 billion notes offering
The investment-grade debt consists of nine tranches of notes
Bank of America €3 billion senior notes offering
The investment-grade debt offering consists of two tranches
Saavi Energía $1.1 billion senior notes offering and concurrent tender offers
The high-yield notes are due 2035